Log in to save to my catalogue

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and...

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1cc826ca236941e185deaad9d64c993b

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

About this item

Full title

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-04, Vol.11 (1), p.7700-7700, Article 7700

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

GABA
A
-α5 subunit-containing receptors have been shown to play a key modulatory role in cognition and represent a promising drug target for cognitive dysfunction, as well as other disorders. Here we report on the preclinical and early clinical profile of a novel GABA
A
-α5 selective negative allosteric modulator (NAM), basmisanil, whic...

Alternative Titles

Full title

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1cc826ca236941e185deaad9d64c993b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1cc826ca236941e185deaad9d64c993b

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-87307-7

How to access this item